We are live on ! Find out more
CS

Candriam SCA Portfolio holdings

AUM $19.3B
1-Year Est. Return 39.18%
This Fund
S&P 500
This Quarter Est. Return
+0.03%
1 Year Est. Return
+39.18%
3 Year Est. Return
+109.85%
5 Year Est. Return
+149.31%
10 Year Est. Return
+617.16%
AUM
$4B
AUM Growth
+$261M
Cap. Flow
+$281M
Cap. Flow %
7.02%
Top 10 Hldgs %
19.74%
Holding
679
New
127
Increased
246
Reduced
223
Closed
43

Top Buys

Rank Stock Value
1
AMGN icon
Amgen
AMGN
+$104M
2
AAPL icon
Apple
AAPL
+$60.7M
3
AMZN icon
Amazon
AMZN
+$47.5M
4
AXP icon
American Express
AXP
+$28.7M
5
TRV icon
Travelers Companies
TRV
+$27.2M

Top Sells

Rank Stock Value
1
FSLR icon
First Solar
FSLR
+$28.1M
2
JNJ icon
Johnson & Johnson
JNJ
+$28.1M
3
CLX icon
Clorox
CLX
+$26.2M
4
TJX icon
TJX Companies
TJX
+$24.8M
5
MCK icon
McKesson
MCK
+$23.7M

Sector Composition

Rank Sector Weight
1 Healthcare 24.39%
2 Financials 11.87%
3 Technology 10.68%
4 Communication Services 10.67%
5 Consumer Discretionary 9.43%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
APD icon
426
Air Products & Chemicals
APD
$66.3B
$936K 0.02%
+7,065
New +$854K
MUR icon
427
Murphy Oil
MUR
$5.58B
$932K 0.02%
37,188
-65,885
-64% -$1.32M
TFC icon
428
Truist Financial
TFC
$63.2B
$926K 0.02%
+27,986
New +$930K
XLNX
429
DELISTED
Xilinx Inc
XLNX
$924K 0.02%
19,579
+1,155
+6% +$54.2K
WU icon
430
Western Union
WU
$2.57B
$923K 0.02%
48,103
+3,265
+7% +$58.7K
ENB icon
431
Enbridge
ENB
$124B
$921K 0.02%
23,693
-3,049
-11% -$104K
YUM icon
432
Yum! Brands
YUM
$41B
$921K 0.02%
15,739
-61,605
-80% -$3.23M
AORT icon
433
Artivion
AORT
$1.23B
$920K 0.02%
86,000
APOG icon
434
Apogee Enterprises
APOG
$850M
$908K 0.02%
+20,800
New +$825K
CME icon
435
CME Group
CME
$92.2B
$903K 0.02%
9,452
-2,769
-23% -$252K
MDXG icon
436
MiMedx Group
MDXG
$626M
$895K 0.02%
103,000
VRN
437
DELISTED
Veren
VRN
$889K 0.02%
64,265
+34,516
+116% +$399K
HPQ icon
438
HP
HPQ
$23.5B
$887K 0.02%
72,398
-24,171
-25% -$258K
ONCE
439
DELISTED
Spark Therapeutics, Inc. Common Stock
ONCE
$881K 0.02%
30,000
-10,000
-25% -$315K
FL
440
DELISTED
Foot Locker
FL
$878K 0.02%
13,693
+325
+2% +$21.1K
SBAC icon
441
SBA Communications
SBAC
$18.4B
$873K 0.02%
8,760
-20,093
-70% -$1.92M
RDHL
442
Redhill Biopharma
RDHL
$3.85M
$868K 0.02%
71
CHL
443
DELISTED
China Mobile Limited
CHL
$866K 0.02%
+15,705
New +$847K
SRPT icon
444
Sarepta Therapeutics
SRPT
$1.66B
$835K 0.02%
43,000
+23,000
+115% +$402K
MGM icon
445
MGM Resorts International
MGM
$11.7B
$829K 0.02%
38,896
-6,377
-14% -$126K
PLD icon
446
Prologis
PLD
$138B
$828K 0.02%
18,852
+3,395
+22% +$136K
BBBY
447
DELISTED
Bed Bath & Beyond Inc
BBBY
$824K 0.02%
+16,697
New +$782K
AMH icon
448
American Homes 4 Rent
AMH
$12B
$818K 0.02%
+51,750
New +$774K
COL
449
DELISTED
Rockwell Collins
COL
$809K 0.02%
8,821
-1,286
-13% -$112K
AKAM icon
450
Akamai
AKAM
$16.8B
$807K 0.02%
+14,598
New +$742K

Similar funds

Candriam SCA's Q1 2016 Portfolio in Review

As of Q1 2016, Candriam SCA held 679 positions worth $4B, up 7% from $3.74B the previous quarter. Its ten largest holdings account for 20% of the portfolio.

Candriam SCA deployed $281M of net new capital in Q1 2016, opening 127 new positions and adding to 246 existing holdings. Its largest new stake was Amgen: 700,333 shares worth $104M.

By sector, the portfolio is most concentrated in Healthcare at 24% of assets, down from 29% a quarter earlier, followed by Financials and Technology.

On the sell side, the largest reduction was First Solar, an estimated $28.1M trimmed.

  • Candriam SCA's largest Q1 2016 buy was Amgen: 700,333 shares worth $104M.
  • Candriam SCA added most to Mead Johnson Nutrition Company in Q1 2016, an estimated $22.2M increase.
  • Candriam SCA's biggest Q1 2016 reduction was First Solar, cutting an estimated $28.1M.
  • Candriam SCA fully exited Avangrid, Inc. in Q1 2016, selling an estimated $9.6M.
  • Candriam SCA's ten largest holdings make up 20% of its $4B portfolio in Q1 2016.
  • Candriam SCA opened 127 new positions and closed 43 in Q1 2016.
  • Candriam SCA's portfolio value rose 7% quarter-over-quarter to $4B.

Based on Candriam SCA's 13F filing for Q1 2016, filed 27 Apr 2016.